← Back to Directory

Testosterone Replacement Therapy

TRT, Testosterone Therapy

Visual ViewRaw Data

Meta Information

ID:testosterone-replacement-therapy
Name:Testosterone Replacement Therapy
Schema Version:1.5

Alternate Names

  • TRT
  • Testosterone Therapy

Active Compound

testosterone

Intervention Type

therapeutic_agent

Delivery

Route:
subcutaneous_injection
Scope:
  • systemic

Regulatory Status

  • us:rx_drug
  • eu:rx_drug
  • ca:rx_drug

Indication

Focus:
disease_treatment
Description:
Treatment of clinically diagnosed hypogonadism in men, alleviating associated symptoms.

Typical Protocol

  • Injectable protocols often involve intramuscular or subcutaneous injections of 50-100 mg once or twice weekly.
  • Transdermal gels or patches are applied daily to the skin, delivering varying doses based on product and patient response.
  • Testosterone pellets may be implanted subcutaneously every 3-6 months, releasing the hormone gradually.

Expected Cost Mean

Low Cost:
30
High Cost:
250
Cost Type:
monthly
Description:
Monthly medication cost varies by formulation and insurance coverage; often covered for hypogonadism.

Summary

Testosterone Replacement Therapy (TRT) involves administering exogenous testosterone to restore physiological levels in individuals with clinically diagnosed hypogonadism. It aims to alleviate symptoms such as low libido, fatigue, decreased muscle mass, and mood disturbances by activating androgen receptors. While effective for hypogonadism, its role in general healthspan extension for eugonadal men remains unproven and potentially risky.

Purpose

Replaces deficient endogenous testosterone to alleviate hypogonadism symptoms.

Card Summary

Treats diagnosed hypogonadism by restoring testosterone levels, improving related symptoms.

Drug Class

androgen

Drugs In Class

Empty Array

Impact

Score:
7.5
Justification:
Restores hormone levels, improving symptoms of clinically diagnosed hypogonadism.

Evidence

Grade:
A
Score:
9
Justification:
Numerous human RCTs confirm efficacy in treating male hypogonadism.

Safety

Score:
5.5
Justification:
Common side effects, requires medical supervision and regular monitoring.

Flags

  • May increase hematocrit (polycythemia) requiring therapeutic phlebotomy.
  • Can suppress endogenous testosterone production and impair fertility.
  • Potential for prostate enlargement or exacerbation of existing prostate conditions.
  • Controversial cardiovascular safety concerns in some populations; requires careful assessment.
  • Requires regular blood tests to monitor testosterone levels, hematocrit, and prostate-specific antigen (PSA).
  • Possible side effects include fluid retention, acne, sleep apnea exacerbation, and mood changes.

Verdict

Effective for diagnosed hypogonadism; requires medical oversight due to risks.